| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/07/2001 | CN1062860C Triazine contg. anionic compounds useful as antiviral agents |
| 03/07/2001 | CN1062859C Substd 1-naphthoyl guanidines, their preparing method, use and drug contg. them |
| 03/07/2001 | CN1062858C Phenyl-substd alkenylcarboguanidides carrying perfluoroalkyl groups, process for their preparation, their use as medicament and medicines |
| 03/07/2001 | CN1062854C Salmeterol kinafoate with controlled particulate size |
| 03/07/2001 | CN1062751C Compound Chinese and western medicinal composition for treating diabets of kidney type |
| 03/07/2001 | CN1062739C Medicine for preventing sexual disease |
| 03/07/2001 | CN1062737C Medicament for preventing and treating several fish diseases |
| 03/07/2001 | CN1062736C External use emulsion for treating burn |
| 03/07/2001 | CN1062735C Use of bisphosphonic acid derivs. for preparation of drugs intended for promoting bone repair |
| 03/07/2001 | CN1062734C Immunopotentiator for treating disease caused by toxic reaction of excessive free radicals |
| 03/07/2001 | CN1062733C Liposome preparing process and preparation |
| 03/07/2001 | CN1062732C Use of compositions based on alpha-pyrones for inducing and stimulating hair growth and/or retarding hair loss |
| 03/07/2001 | CN1062722C Double fibre sugar reducing powder and its preparing method |
| 03/07/2001 | CA2311035A1 Use of simethicone to treat ulcerative colitis |
| 03/07/2001 | CA2281837A1 Solid pharmaceutical composition comprising a retinoid and polyethylene glycol |
| 03/06/2001 | US6197993 Prostaglandin e2 antagonists or agonists |
| 03/06/2001 | US6197982 Vitamin D analogues |
| 03/06/2001 | US6197980 4-Acetoxy-2α-benzoyloxy-5β,20-epoxy-1β,7β,10β-trihydroxy-9-oxo-11-taxen-13α-yl(2R,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate trihydrate |
| 03/06/2001 | US6197978 Process for the manufacture of 3-N-N-dicyclobutylamino-8-fluoro-3, 4-dihydro-2H-1-benzopyran-5-carboxamide |
| 03/06/2001 | US6197975 7-azabicyclo(2.2.1)heptane-7-carbonyl-substituted 2-phenylindole derivatives; sexual disorders; anticarcinogenic agents |
| 03/06/2001 | US6197972 Chemical intermediates for anticholesterol agents |
| 03/06/2001 | US6197959 Piperidine derivatives |
| 03/06/2001 | US6197958 Carboxylic acid derivatives, their preparation and use |
| 03/06/2001 | US6197955 Production of staurosporine derivative using acid isomerization |
| 03/06/2001 | US6197943 Preparation of a salt of an organic base of the starting glycosaminoglycans, partial solvolytic desulfation of the salts by treatment with aprotic polar solvent containing methanol, n-resulfation of the partially desulfated product |
| 03/06/2001 | US6197911 Siloxane dyes, compositions containing same and uses thereof |
| 03/06/2001 | US6197834 Method of inhibiting formation of infectious herpes virus particles |
| 03/06/2001 | US6197833 Neuroprotective effects of polycyclic phenolic compounds |
| 03/06/2001 | US6197832 Composition for reducing serum cholesterol levels |
| 03/06/2001 | US6197831 Administering effective amount of a thiol or reducible disulfide compound, mesna acts as a protective agent for cytotoxic agents, |
| 03/06/2001 | US6197830 Tricyclic antidepressants mixed with one or more topical bases, and applying to the skin above areas affected by pain. |
| 03/06/2001 | US6197829 For the transplantation of organs and autoimmune diseases. in order to inhibit rejection reaction at organs or bone marrow and treat autoimmune diseases and allergic diseases; fingolimod is title compound |
| 03/06/2001 | US6197828 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 03/06/2001 | US6197827 Nicotine receptor antagonists and either an anti-depressant or an anti-anxiety drug, mecamylamine and bupropion |
| 03/06/2001 | US6197826 α-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation |
| 03/06/2001 | US6197825 Azulenyl nitrone spin trapping agents, methods of making and using same |
| 03/06/2001 | US6197824 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect |
| 03/06/2001 | US6197823 Pain reliever and method of use |
| 03/06/2001 | US6197822 Neuropeptide antagonists |
| 03/06/2001 | US6197821 New use of 15-keto-prostaglandin e compounds, hypertension, buerger disease, raynaud disease, asthma, eyegrounds--amphiblestrodes, chorioidea, diabetes, arterial sclerosis, renal failure, cardiac infarction, angina pectoris |
| 03/06/2001 | US6197820 Use of phenylglycine derivatives to decrease neuronal death caused by brain tumors and brain lesions |
| 03/06/2001 | US6197819 Treatment of seizure disorders. activate gad, bind a novel binding site which was identified to bind tritiated gabapentin. |
| 03/06/2001 | US6197818 Use of rhein or the salt thereof, |
| 03/06/2001 | US6197817 Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders |
| 03/06/2001 | US6197816 Activates tyrosine kinase activity, e.g., insulin receptor tyrosine kinase activity. |
| 03/06/2001 | US6197815 Animal feed additive by preparing metal amino acid chelates, increasing desired metal uptake by the animal, and concomitant growth facilitation and enhancement for the treated animals. |
| 03/06/2001 | US6197813 At least one aldonic compound, a water-soluble zinc salt. |
| 03/06/2001 | US6197812 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 03/06/2001 | US6197811 Synthetic derivatives of phomalactone, a known compound obtainable by fermentation of the fungus phomopsis sp, have activity as inhibitors of cytokine production in treatment of disorders requiring immunosuppression, for example |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197808 Methods for treating hyperplasia |
| 03/06/2001 | US6197806 Eliminating agent for activated oxygen and free radicals |
| 03/06/2001 | US6197803 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 03/06/2001 | US6197801 Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 03/06/2001 | US6197800 Hypotensive agents; cardiovascular disorders |
| 03/06/2001 | US6197798 Inhibitors of microsomal triglyceride transfer protein |
| 03/06/2001 | US6197797 Cyanoguanidines as cell proliferation inhibitors |
| 03/06/2001 | US6197796 Anticancer composition comprising a diaminotrifluoromethylpyridine derivative |
| 03/06/2001 | US6197793 Hemoregulatory compounds |
| 03/06/2001 | US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/06/2001 | US6197790 Benzothiophene compounds, intermediates, compositions, and methods |
| 03/06/2001 | US6197789 Antidiabetic agents |
| 03/06/2001 | US6197788 (−)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders |
| 03/06/2001 | US6197787 Pharmaceutical formulations containing poorly soluble drug substances |
| 03/06/2001 | US6197786 Anticholesterol agents |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 03/06/2001 | US6197783 Therapy for gastrointestinal disorders |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197781 Spray drying mixture of rapamycin suspension and carrier |
| 03/06/2001 | US6197780 Administering an endothelin anatgonist |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197776 Method for treatment of reactive arthritis or bursitis |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/06/2001 | US6197772 1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives |
| 03/06/2001 | US6197770 Alkenyl- and alkynl-containing metalloprotease inhibitors |
| 03/06/2001 | US6197769 Serotonine receptors antagonist; gastrointestinal disorders, antiarrhythmia agents; incontinence |
| 03/06/2001 | US6197768 Therapy, prevention ischemic heart disease |
| 03/06/2001 | US6197767 Arglabin compounds and therapeutic uses thereof |
| 03/06/2001 | US6197765 Adjust blood glucose, insulin concentration |
| 03/06/2001 | US6197764 Clozapine compositions and uses thereof |
| 03/06/2001 | US6197763 Using a metallic complex of lawsone or tropolone |
| 03/06/2001 | US6197762 Nitrosated and nitrosylated steroids compositions, and methods for treating respiratory disorders |
| 03/06/2001 | US6197761 17β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives |
| 03/06/2001 | US6197760 Isophosphoramide mustard analogs and use thereof |
| 03/06/2001 | US6197759 Osteoblast-specific mitogens and drugs containing such compounds |
| 03/06/2001 | US6197758 Methods for supplying postgastrectomic mineral and methods for treating postgastrectomic syndrome |
| 03/06/2001 | US6197754 Tyrosine kinase inhibitor |
| 03/06/2001 | US6197753 Antiarthritic agents; antihistamines |
| 03/06/2001 | US6197752 Tetrahydrofuran or tetrahydropyran compound; therapy for autoimmune disease, antiallergens, antiinflammatory agents |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/06/2001 | US6197749 Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes |
| 03/06/2001 | US6197748 Ketoheterocyclic inhibitors of factor Xa |
| 03/06/2001 | US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| 03/06/2001 | US6197743 Concurrent administering induction agent and viricides |
| 03/06/2001 | US6197580 Transcriptional regulation of the human β3-adrenergic receptor gene |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197521 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 03/06/2001 | US6197519 Pancreas-derived serpin |
| 03/06/2001 | US6197349 Supercooling a melt of poor water soluble substance, stabilizer, mixing and cooling |
| 03/06/2001 | US6197348 Taste masked liquid suspensions |